MC Plus Material – 08_Overview of the FY2026 Medical Fee Revision: 8. Promotion of High

News Highlights

The “Overview of the FY2026 Medical Fee Revision” published by the Center for Health Policy Information highlights the promotion of high-quality home healthcare as a key focus. This revision has the potential to significantly impact the management and succession strategies of medical institutions. In particular, it is pointed out that group participation leveraging economies of scale and utilizing tax benefits by transitioning to specific medical corporations or social medical corporations are key to mid-to-long-term management stability and smooth business succession.

Perspective from M&A Medical Editorial Department

The overview of the FY2026 medical fee revision, especially the focus on “Promotion of High-Quality Home Healthcare,” presents an urgent issue for medical institutions concentrating on home healthcare. The necessity of mid-to-long-term management and succession strategies with an eye on the revision cycle goes beyond mere system compliance. For example, staffing, capital investment, and strengthening interdisciplinary collaboration to cope with an increase in home patients and their severity may become an excessive burden for individual medical institutions alone. Under these circumstances, M&A, which allows for enjoying economies of scale through group formation and dispersing the burden of facility maintenance and capital investment, can be an effective option for both business continuity and quality assurance. Furthermore, considering tax schemes with a view to transitioning to specific medical corporations or social medical corporations directly leads to reducing future succession costs. This revision overview can be said to be prompting a reconstruction of the home healthcare provision system and a fundamental review of associated management and succession strategies.

Points Raised by This News

• The medical fee revision aimed at improving the quality of home healthcare suggests a risk of increased investment burden for individual medical institutions.
• Economies of scale through group formation contribute to maintaining facility standards and dispersing the burden of capital investment.
• Transitioning to specific medical corporations or social medical corporations leads to tax benefits and smoother business succession.
• The FY2026 revision is a factor accelerating the review of M&A and business succession strategies for home healthcare providers.

Practical Questions Arising from This News

• What are the specific guidelines for capital investment and staffing to respond to the improvement of home healthcare quality?
• If participating in a group, to what extent can the independence of the current medical corporation be maintained?
• What procedures and requirements are necessary for transitioning to a specific medical corporation or social medical corporation?

If You Feel “Should I Consult About This?”

If your institution is planning management and capital investments aligned with the revision’s direction of improving the quality of home healthcare, you should consider the risk of increased burden and explore solutions through economies of scale via M&A or the utilization of tax schemes. In particular, if you are considering future business succession, please consult with an expert once to determine if it is possible to achieve both the maintenance and strengthening of competitiveness and smooth succession by exploring the possibilities of group formation or corporate status transition.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a Small and Medium Enterprise Agency-certified M&A support institution on a full success fee basis. Consultations are accepted with strict confidentiality. Free consultation here